☰

Todd A. Verdoorn - Publications

Affiliations: 
NeuroTherapeutics Pharma, Inc 
Area:
pain
Tree Info Grants Similar researchers PubMed Report error

21/46 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2003 Sikes JSS, Verdoorn T. Lysine 445 is a molecular indicator of subunit-specific AMPA: Receptor binding domains Neuroscience Research Communications. 32: 143-150. DOI: 10.1002/nrc.10069  0.329
1998 Weaver CD, Partridge JG, Yao TL, Moates JM, Magnuson MA, Verdoorn TA. Activation of glycine and glutamate receptors increases intracellular calcium in cells derived from the endocrine pancreas. Molecular Pharmacology. 54: 639-46. PMID 9765506  0.425
1996 Weaver CD, Yao TL, Powers AC, Verdoorn TA. Differential expression of glutamate receptor subtypes in rat pancreatic islets. The Journal of Biological Chemistry. 271: 12977-84. PMID 8662728 DOI: 10.1074/jbc.271.22.12977  0.529
1995 Li F, Owens N, Verdoorn TA. Functional effects of mutations in the putative agonist binding region of recombinant alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors. Molecular Pharmacology. 47: 148-54. PMID 7838123  0.504
1995 Anegawa NJ, Lynch DR, Verdoorn TA, Pritchett DB. Transfection of N-methyl-D-aspartate receptors in a nonneuronal cell line leads to cell death. Journal of Neurochemistry. 64: 2004-12. PMID 7722486 DOI: 10.1046/J.1471-4159.1995.64052004.X  0.496
1995 Johansen TH, Chaudhary A, Verdoorn TA. Interactions among GYKI-52466, cyclothiazide, and aniracetam at recombinant AMPA and kainate receptors. Molecular Pharmacology. 48: 946-55. PMID 7476926  0.5
1994 Verdoorn TA, Johansen TH, Drejer J, Nielsen EO. Selective block of recombinant glur6 receptors by NS-102, a novel non-NMDA receptor antagonist. European Journal of Pharmacology. 269: 43-9. PMID 7828657  0.516
1994 Lynch DR, Anegawa NJ, Verdoorn T, Pritchett DB. N-methyl-D-aspartate receptors: different subunit requirements for binding of glutamate antagonists, glycine antagonists, and channel-blocking agents. Molecular Pharmacology. 45: 540-5. PMID 7511781  0.533
1992 Sommer B, Monyer H, Wisden W, Verdoorn TA, Burnashev N, Sprengel R, Sakmann B, Seeburg PH. Glutamate-gated ion channels in the brain. Genetic mechanism for generating molecular and functional diversity. Arzneimittel-Forschung. 42: 209-10. PMID 1375026  0.709
1992 Sommer B, Burnashev N, Verdoorn TA, Keinänen K, Sakmann B, Seeburg PH. A glutamate receptor channel with high affinity for domoate and kainate. The Embo Journal. 11: 1651-6. PMID 1373382 DOI: 10.1002/J.1460-2075.1992.Tb05211.X  0.747
1992 Stein E, Cox JA, Seeburg PH, Verdoorn TA. Complex pharmacological properties of recombinant alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate receptor subtypes. Molecular Pharmacology. 42: 864-71. PMID 1279377  0.514
1991 Verdoorn TA, Burnashev N, Monyer H, Seeburg PH, Sakmann B. Structural determinants of ion flow through recombinant glutamate receptor channels. Science (New York, N.Y.). 252: 1715-8. PMID 1710829 DOI: 10.1126/Science.1710829  0.713
1990 Keinänen K, Wisden W, Sommer B, Werner P, Herb A, Verdoorn TA, Sakmann B, Seeburg PH. A family of AMPA-selective glutamate receptors. Science (New York, N.Y.). 249: 556-60. PMID 2166337 DOI: 10.1126/Science.2166337  0.702
1990 Seeburg PH, Wisden W, Verdoorn TA, Pritchett DB, Werner P, Herb A, Lüddens H, Sprengel R, Sakmann B. The GABAA receptor family: molecular and functional diversity. Cold Spring Harbor Symposia On Quantitative Biology. 55: 29-40. PMID 1966765 DOI: 10.1101/Sqb.1990.055.01.006  0.567
1990 Sommer B, Keinänen K, Verdoorn TA, Wisden W, Burnashev N, Herb A, Köhler M, Takagi T, Sakmann B, Seeburg PH. Flip and flop: a cell-specific functional switch in glutamate-operated channels of the CNS. Science (New York, N.Y.). 249: 1580-5. PMID 1699275 DOI: 10.1126/Science.1699275  0.744
1990 Verdoorn TA, Draguhn A, Ymer S, Seeburg PH, Sakmann B. Functional properties of recombinant rat GABAA receptors depend upon subunit composition. Neuron. 4: 919-28. PMID 1694446 DOI: 10.1016/0896-6273(90)90145-6  0.626
1990 Sakmann B, Schrader J, Brenner B, Murer H, Boeckh J, Handwerker HO, HonerjÄger P, Dugas M, Wang G, DeLuca A, Brinkmeier H, Fakler B, Pröbstle T, Rüdel R, Pohl J-, ... ... Verdoorn TA, et al. Abstract of the 68th Meeting (Spring Meeting) 6–9 March 1990, Heidelberg PflüGers Archiv. 415: R1-R119. DOI: 10.1007/Bf02912664  0.588
1989 Verdoorn TA, Kleckner NW, Dingledine R. N-methyl-D-aspartate/glycine and quisqualate/kainate receptors expressed in Xenopus oocytes: antagonist pharmacology. Molecular Pharmacology. 35: 360-8. PMID 2564633  0.666
1988 Verdoorn TA, Dingledine R. Excitatory amino acid receptors expressed in Xenopus oocytes: agonist pharmacology. Molecular Pharmacology. 34: 298-307. PMID 2901662  0.665
1988 Dingledine R, Boland LM, Chamberlin NL, Kawasaki K, Kleckner NW, Traynelis SF, Verdoorn TA. Amino acid receptors and uptake systems in the mammalian central nervous system. Critical Reviews in Neurobiology. 4: 1-96. PMID 2461808  0.72
1987 Verdoorn TA, Kleckner NW, Dingledine R. Rat brain N-methyl-D-aspartate receptors expressed in Xenopus oocytes. Science (New York, N.Y.). 238: 1114-6. PMID 2825347 DOI: 10.1126/Science.2825347  0.733
Low-probability matches (unlikely to be authored by this person)
1994 Verdoorn TA. Formation of heteromeric gamma-aminobutyric acid type A receptors containing two different alpha subunits. Molecular Pharmacology. 45: 475-80. PMID 8145733  0.29
1997 Utz AL, Verdoorn TA. Recombinant AMPA receptors with low Ca2+ permeability increase intracellular Ca2+ in HEK 293 cells. Neuroreport. 8: 1975-80. PMID 9223088  0.266
1998 Weaver CD, Gundersen V, Verdoorn TA. A high affinity glutamate/aspartate transport system in pancreatic islets of Langerhans modulates glucose-stimulated insulin secretion. The Journal of Biological Chemistry. 273: 1647-53. PMID 9430708 DOI: 10.1074/jbc.273.3.1647  0.254
2023 Dwyer MKR, Amelinez-Robles N, Polsfuss I, Herbert K, Kim C, Varghese N, Parry TJ, Buller B, Verdoorn TA, Billing CB, Morrison B. NTS-105 decreased cell death and preserved long-term potentiation in an in vitro model of moderate traumatic brain injury. Experimental Neurology. 114608. PMID 37949202 DOI: 10.1016/j.expneurol.2023.114608  0.236
1998 Zhou Q, Verdoorn TA, Lovinger DM. Alcohols potentiate the function of 5-HT3 receptor-channels on NCB-20 neuroblastoma cells by favouring and stabilizing the open channel state. The Journal of Physiology. 507: 335-52. PMID 9518697 DOI: 10.1111/j.1469-7793.1998.335bt.x  0.235
1996 Fritz ID, Hale N, Utz A, Northington J, Wu L, Powers AC, Verdoorn T, Robertson D. Altering neurotransmitter levels in vitro following glutamate decarboxylase gene transfer Faseb Journal. 10: A1285.  0.233
2013 Verdoorn T, Zhao F, Whyment A, Morton K, Wei H, Fang X, Jeggo R, Spanswick D, Wanaski S, Collins S. NP260, a novel GABA-A receptor antagonist, dampens neuronal hyperexcitability and relieves mechanical allodynia in a rat model of neuropathic pain The Journal of Pain. 14: S69. DOI: 10.1016/J.Jpain.2013.01.614  0.218
2004 Sit SY, Xie K, Jacutin-Porte S, Boy KM, Seanz J, Taber MT, Gulwadi AG, Korpinen CD, Burris KD, Molski TF, Ryan E, Xu C, Verdoorn T, Johnson G, Nichols DE, et al. Synthesis and SAR exploration of dinapsoline analogues. Bioorganic & Medicinal Chemistry. 12: 715-34. PMID 14759732 DOI: 10.1016/j.bmc.2003.11.015  0.211
1997 Fritz JD, Utz AL, Hale NM, Wu L, Powers AC, Verdoorn TA, Robertson D. Gene-based neurotransmitter modulation in cerebellar granule neurons. Journal of Neurochemistry. 68: 204-12. PMID 8978727 DOI: 10.1046/J.1471-4159.1997.68010204.X  0.178
1986 Lauder JM, Han VK, Henderson P, Verdoorn T, Towle AC. Prenatal ontogeny of the GABAergic system in the rat brain: an immunocytochemical study. Neuroscience. 19: 465-93. PMID 3022187 DOI: 10.1016/0306-4522(86)90275-7  0.162
2002 Sit SY, Xie K, Jacutin-Porte S, Taber MT, Gulwadi AG, Korpinen CD, Burris KD, Molski TF, Ryan E, Xu C, Wong H, Zhu J, Krishnananthan S, Gao Q, Verdoorn T, et al. (+)-Dinapsoline: an efficient synthesis and pharmacological profile of a novel dopamine agonist. Journal of Medicinal Chemistry. 45: 3660-8. PMID 12166939 DOI: 10.1021/jm0101545  0.132
2023 Verdoorn TA, Parry TJ, Pinna G, Lifshitz J. Neurosteroid Receptor Modulators for Treating Traumatic Brain Injury. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. 20: 1603-1615. PMID 37653253 DOI: 10.1007/s13311-023-01428-7  0.119
2005 Barten DM, Guss VL, Corsa JA, Loo A, Hansel SB, Zheng M, Munoz B, Srinivasan K, Wang B, Robertson BJ, Polson CT, Wang J, Roberts SB, Hendrick JP, Anderson JJ, ... ... Verdoorn TA, et al. Dynamics of {beta}-amyloid reductions in brain, cerebrospinal fluid, and plasma of {beta}-amyloid precursor protein transgenic mice treated with a {gamma}-secretase inhibitor. The Journal of Pharmacology and Experimental Therapeutics. 312: 635-43. PMID 15452193 DOI: 10.1124/jpet.104.075408  0.083
2002 Bollini S, Herbst JJ, Gaughan GT, Verdoorn TA, Ditta J, Dubowchik GM, Vinitsky A. High-throughput fluorescence polarization method for identification of FKBP12 ligands. Journal of Biomolecular Screening. 7: 526-30. PMID 14599350 DOI: 10.1177/1087057102238626  0.074
2011 Verdoorn TA, McCarten JR, Arciniegas DB, Golden R, Moldauer L, Georgopoulos A, Lewis S, Cassano M, Hemmy L, Orr W, Rojas DC. Evaluation and tracking of Alzheimer's disease severity using resting-state magnetoencephalography. Journal of Alzheimer's Disease : Jad. 26: 239-55. PMID 21971464 DOI: 10.3233/Jad-2011-0056  0.06
2001 Dubowchik GM, Vrudhula VM, Dasgupta B, Ditta J, Chen T, Sheriff S, Sipman K, Witmer M, Tredup J, Vyas DM, Verdoorn TA, Bollini S, Vinitsky A. 2-Aryl-2,2-difluoroacetamide FKBP12 ligands: synthesis and X-ray structural studies. Organic Letters. 3: 3987-90. PMID 11735566 DOI: 10.1021/ol0166909  0.05
2019 Alexander-Curtis M, Pauls R, Chao J, Volpi JJ, Bath PM, Verdoorn TA. Human tissue kallikrein in the treatment of acute ischemic stroke. Therapeutic Advances in Neurological Disorders. 12: 1756286418821918. PMID 30719079 DOI: 10.1177/1756286418821918  0.048
2010 Verdoorn TA, Cassano M, Lewis S, Golden R. P3-247: Functional signatures of Alzheimer's disease progression and severity revealed by magnetoencephalography Alzheimer's & Dementia. 6: S523-S524. DOI: 10.1016/j.jalz.2010.05.1746  0.042
2017 Alexander-Curtis M, Duan J, Seeklander A, Scott S, Norton N, Wong CL, Salman S, Verdoorn TA. Safety, tolerability and pharmacokinetic profile of recombinant human tissue kallikrein, DM199, after intravenous and subcutaneous administration in healthy volunteers International Journal of Clinical Trials. 4: 139. DOI: 10.18203/2349-3259.IJCT20174861  0.041
2022 Zhang L, Schwartz-Byrne R, Gertz S, McGuire M, Woodhouse C, Powell B, Wei M, Li C, Billing CB, Verdoorn TA, Lam L, Parry TJ, Buller B, Zhang ZG, Poulsen D, et al. Pharmacological Characterization of a Novel Neuroactive Steroid Prodrug, NTS-104, and Its Neuroprotective Activity in Experimental Stroke Models. Stroke. 101161STROKEAHA12203. PMID 36168130 DOI: 10.1161/STROKEAHA.122.038507  0.024
2011 Verdoorn TA, McCarten JR, Arcienegas DB, Golden R, Moldauer L, Georgopoulos A, Lewis S, Cassano M, Hemmy L, Orr W, Rojas DC. Evaluation and tracking of Alzheimer's disease severity using resting-state magnetoencephalography Advances in Alzheimer's Disease. 2: 445-461. DOI: 10.3233/978-1-60750-793-2-445  0.02
2011 Verdoorn T, Rajagovindan R, Cassano M. P2-079: Multivariate models of Alzheimer's disease progression based on resting-state MEG scans Alzheimer's & Dementia. 7: S332-S333. DOI: 10.1016/j.jalz.2011.05.969  0.019
2009 Verdoorn TA, Cassano M, Georgopoulos A, Lewis S, McCarten R, Hemmy L, Golden R, Rojas D, Moldauer L, Arciniegas D. P2-003: Characterization of Alzheimer's pathology by magnetoencephalography and the synchronous neural interaction test Alzheimer's & Dementia. 5: P260-P261. DOI: 10.1016/J.Jalz.2009.04.312  0.018
2009 Verdoorn TA, Cassano M, Georgopoulos A, Lewis S, McCarten R, Hemmy L, Golden R, Rojas D, Moldauer L, Arciniegas D. IC-P-115: Characterization of Alzheimer pathology by magnetoencephalography and the synchronous neural interaction test Alzheimer's & Dementia. 5: P48-P48. DOI: 10.1016/j.jalz.2009.05.087  0.012
1999 Verdoorn TA. Approaches toward development of a disease modifying treatment for Alzheimer's disease Cns Drug Reviews. 5: 12.  0.011
Hide low-probability matches.